Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Novartis drops out of hep C race, punting a $440M Enanta pact
Novartis drops out of hep C race, punting a $440M Enanta pact
Novartis drops out of hep C race, punting a $440M Enanta pact
Submitted by
admin
on October 1, 2014 - 9:19am
Source:
Fierce Biotech
News Tags:
Novartis
hepatitis C
Enanta Pharmaceuticals
EDP-239
alisporivir
Headline:
Novartis drops out of hep C race, punting a $440M Enanta pact
Do Not Allow Advertisers to Use My Personal information
